These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11363265)

  • 1. Plasma donor's HIV went undetected in repeated tests.
    AIDS Policy Law; 1996 Mar; 11(5):2. PubMed ID: 11363265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV antigen test of blood donors].
    Knödler B; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():10-1. PubMed ID: 8374280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV transmissions from a window-period platelet donation.
    Kopko PM; Fernando LP; Bonney EN; Freeman JL; Holland PV
    Am J Clin Pathol; 2001 Oct; 116(4):562-6. PubMed ID: 11601141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. U.S. Public Health Service guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen.
    MMWR Recomm Rep; 1996 Mar; 45(RR-2):1-9. PubMed ID: 8604210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assay for simultaneous detection of HIV p24 antigen and anti-HIV antibody].
    Xu K; Zhang Y; Wang Y; Mbawuike I
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):377-9. PubMed ID: 12665911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HIV-p24 antigen test in blood donors: yes or no?].
    Caspari G; Gerlich WH
    Med Klin (Munich); 1994 Jan; 89(1):25-32, 47. PubMed ID: 8145675
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood safety: improvements needed in Thailand.
    AIDS Wkly Plus; 1996 Oct 7-14; ():16. PubMed ID: 12291667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasensitive quantitative HIV-1 p24 antigen assay adapted to dried plasma spots to improve treatment monitoring in low-resource settings.
    Knuchel MC; Tomasik Z; Speck RF; Lüthy R; Schüpbach J
    J Clin Virol; 2006 May; 36(1):64-7. PubMed ID: 16431154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
    van Hulst M; Sagoe KW; Vermande JE; van der Schaaf IP; van der Tuuk Adriani WP; Torpey K; Ansah J; Mingle JA; Smit Sibinga CT; Postma MJ
    Value Health; 2008; 11(5):809-19. PubMed ID: 18489518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First report of human immunodeficiency virus transmission via an RNA-screened blood donation.
    Delwart EL; Kalmin ND; Jones TS; Ladd DJ; Foley B; Tobler LH; Tsui RC; Busch MP
    Vox Sang; 2004 Apr; 86(3):171-7. PubMed ID: 15078251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS prevention is thicker than blood. Zimbabwe.
    Steinberg J
    Links; 1992; 9(2):3. PubMed ID: 12159269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual risk of HIV-1 transmission: the case of a seroconverter.
    Miceli M; Giuliani M; Gallo A; Mercurio G; Crescimbeni E; Iudicone P
    Clin Lab; 2002; 48(5-6):283-6. PubMed ID: 12071578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States.
    Zou S; Notari EP; Fang CT; Stramer SL; Dodd RY
    Transfusion; 2009 Apr; 49(4):655-61. PubMed ID: 19170999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
    Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
    Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen testing for human immunodeficiency virus (HIV) and the magnet effect: will the benefit of a new HIV test be offset by the numbers of higher risk, test-seeking donors attracted to blood centers? Retrovirus Epidemiology Donor Study.
    Korelitz JJ; Busch MP; Williams AE
    Transfusion; 1996 Mar; 36(3):203-8. PubMed ID: 8604502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of FDA licensed HIV assays using plasma from Cameroonian blood donors.
    Lee S; Hu J; Tang S; Wood O; Francis K; Machuca A; Rios M; Daniel S; Vockley C; Awazi B; Zekeng L; Hewlett I
    J Med Virol; 2006; 78 Suppl 1():S22-3. PubMed ID: 16622873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New test dissociates HIV antigen from antibody.
    Oncology (Williston Park); 1992 Jan; 6(1):85-6. PubMed ID: 1531605
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative evaluation of TRI-DOT Rapid HIV test with fourth-generation ELISA for the detection of human immunodeficiency virus.
    Sudha T; Teja VD; Gopal M; Rajesh M; Lakshmi V
    Clin Microbiol Infect; 2005 Oct; 11(10):850-2. PubMed ID: 16153264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic evaluation of a new combined HIV p24 antigen and anti-HIV1/2/O screening assay.
    Polywka S; Feldner J; Duttmann H; Laufs R
    Clin Lab; 2001; 47(7-8):351-6. PubMed ID: 11499796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.